Viatris Total Assets 2010-2024 | VTRS

Viatris total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Viatris total assets for the quarter ending June 30, 2024 were $45.330B, a 6.91% decline year-over-year.
  • Viatris total assets for 2023 were $47.686B, a 4.67% decline from 2022.
  • Viatris total assets for 2022 were $50.022B, a 8.79% decline from 2021.
  • Viatris total assets for 2021 were $54.843B, a 10.9% decline from 2020.
Viatris Annual Total Assets
(Millions of US $)
2023 $47,686
2022 $50,022
2021 $54,843
2020 $61,553
2019 $31,256
2018 $32,735
2017 $35,806
2016 $34,726
2015 $22,268
2014 $15,821
2013 $15,295
2012 $11,932
2011 $11,598
2010 $11,537
2009 $10,802
Viatris Quarterly Total Assets
(Millions of US $)
2024-06-30 $45,330
2024-03-31 $47,344
2023-12-31 $47,686
2023-09-30 $48,743
2023-06-30 $48,695
2023-03-31 $49,290
2022-12-31 $50,022
2022-09-30 $48,663
2022-06-30 $51,125
2022-03-31 $53,467
2021-12-31 $54,843
2021-09-30 $56,070
2021-06-30 $57,984
2021-03-31 $58,979
2020-12-31 $61,553
2020-09-30 $31,243
2020-06-30 $30,155
2020-03-31 $30,146
2019-12-31 $31,256
2019-09-30 $31,054
2019-06-30 $31,817
2019-03-31 $31,907
2018-12-31 $32,735
2018-09-30 $33,456
2018-06-30 $33,272
2018-03-31 $35,185
2017-12-31 $35,806
2017-09-30 $35,819
2017-06-30 $35,506
2017-03-31 $34,273
2016-12-31 $34,726
2016-09-30 $36,539
2016-06-30 $28,836
2016-03-31 $22,644
2015-12-31 $22,268
2015-09-30 $21,317
2015-06-30 $22,795
2015-03-31 $22,124
2014-12-31 $15,821
2014-09-30 $15,174
2014-06-30 $15,603
2014-03-31 $15,355
2013-12-31 $15,295
2013-09-30 $12,902
2013-06-30 $12,212
2013-03-31 $11,885
2012-12-31 $11,932
2012-09-30 $11,706
2012-06-30 $11,602
2012-03-31 $11,934
2011-12-31 $11,598
2011-09-30 $11,118
2011-06-30 $12,006
2011-03-31 $11,878
2010-12-31 $11,537
2010-09-30 $11,407
2010-06-30 $10,598
2010-03-31 $10,823
2009-12-31 $10,802
2009-09-30 $10,763
2009-06-30 $10,243
2009-03-31 $9,897
Sector Industry Market Cap Revenue
Medical Medical Services $13.858B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00